AB Cube is a France based startup that has been operational since 2006. The company offers a cloud-based drug safety solution, SafetyEasy® Suite, which caters to the safety vigilance requirements of a wide range of organizations, from research centers to pharmaceutical and biotechnology firms. The company's solutions are designed to address the challenges of international safety regulations, such as combination product reporting, and include dedicated offerings for pharmacovigilance, medical device safety, biovigilance, nutrivigilance, and cosmetovigilance. Notably, AB Cube has embraced the power of SaaS, making its solutions flexible and compliant. The company's iTAP® – Triage tool automates ICSRs activities, offering a significant improvement in efficiency. AB Cube has a significant client base, with over 400 databases installed globally and more than 2000 unique users. Its clients span diverse organizations, from academia to CROs and pharmaceutical companies across various countries. The company's systems are validated according to GAMP 5 and FDA 21 CFR part 11. In recent years, AB Cube has made strategic developments, such as the launch of SafetyEasy® MI, a dedicated software for Medical Information Management. The company is committed to #makingsafetyeasy and is open to collaborating with organizations looking for multivigilance solutions. Interested parties can reach out through the company's website.
There is no investment information
No recent news or press coverage available for AB Cube.